Aberrant promoter hypermethylation of miR-335 and miR-145 is involved in breast cancer PD-L1 overexpression

Hajibabaei, S; Sotoodehnejadnematalahi, F; Nafissi, N; Zeinali, S; Azizi, M

Azizi, M (通讯作者)，Pasteur Inst Iran, Biotechnol Res Ctr, Mol Med Dept, 69th Pasteur St,Kargar Ave, Tehran, Iran.

SCIENTIFIC REPORTS, 2023; 13 (1):

Abstract

PD-L1 is one of the most important immune checkpoint molecules in breast cancer that plays an important role in suppressing the immune system when con......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索